Legislature(2023 - 2024)DAVIS 106
04/16/2024 03:00 PM House HEALTH & SOCIAL SERVICES
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB285 | |
| HB336 | |
| SB24 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| + | HB 285 | TELECONFERENCED | |
| *+ | HB 336 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
| += | SB 24 | TELECONFERENCED | |
HB 285-MAMMOGRAMS: INSURANCE COVERAGE
3:06:22 PM
CHAIR PRAX announced that the first order of business would be
HOUSE BILL NO. 285, "An Act relating to insurance; relating to
mammograms; and providing for an effective date."
3:06:43 PM
REPRESENTATIVE ZACK FIELDS, Alaska State Legislature, as prime
sponsor, introduced HB 285. He noted that the bill came as a
suggestion from Susan G. Komen, the organization that did the
research on the bill. He stressed that of the different types
of mammograms, many Alaskan women cannot afford diagnostic
imaging exams. He said that the Affordable Care Act (ACA) does
not cover diagnostic screenings; therefore, high risk women who
are not wealthy struggle to pay for these mammograms. He said
that when cancer is detected early, it is less expensive to
treat; the bill would require an up-front cost which pales in
comparison to the cost of delaying detection. He went through
the number of detections in Alaska as well as the rest of the
U.S. He further related impacts in detection in regard to a
woman's race. He drew attention to a slide [hard copy included
in the committee packet], which went over cost comparisons. He
noted many states have enacted this type of legislation and he
welcomed questions from committee members.
3:12:05 PM
COURTNEY OWENS, Staff, Representative Zack Fields, Alaska State
Legislature, on behalf of Representative Fields, prime sponsor,
gave the sectional analysis for HB 285 [included in the
committee packet], which read as follows [original punctuation
provided]:
Section 1: Amends AS 21.42.375(e) to define
"diagnostic breast examination" and "supplemental
breast examination" and offers guidelines for the
basis of additional testing.
Section 2: Adds a new subsection to AS 21.42.375
guaranteeing that mammography screening, diagnostic
breast examinations, and supplemental breast
examinations are covered by applicable insurance
plans, with the exception of high deductible health
plans that are eligible for a health savings account
tax deduction.
Section 3: Amends the law of the State of Alaska by
applying Sec. 1 and Sec. 2 to an insurance policy or
contract on or after the effective date of the law.
Section 4: Amends the law of the State of Alaska to
allow the Division of Insurance to adopt regulations
necessary to implement this act under AS 44.62.
Section 5: Section 4 take effect immediately under AS
01.10.070(c).
Section 6: This Act takes effect January 1, 2025.
3:13:08 PM
REPRESENTATIVE MINA asked what the average cost share of
diagnostic imaging was.
REPRESENTATIVE FIELDS answered that he heard in public testimony
there was a range of rates including hundreds of dollars, but he
did not know if that was the average.
3:13:54 PM
REPRESENTATIVE PRAX offered his belief that diagnostic screening
followed the regular screening.
REPRESENTATIVE FIELDS confirmed that was correct. For the high-
risk group, which he noted in Alaska is 12,000 people, it was
recommended by doctors that they have the diagnostic screening.
REPRESENTATIVE PRAX questioned whether the diagnostic screening
would need pre-authorization and why the insurance company
wouldn't pay it.
REPRESENTATIVE FIELDS answered that the issue is that ACA
required no cost share for a standard mammogram, but the
diagnostic would need a co-pay. He went over scenarios where
people may not be able to pay the costs.
3:16:08 PM
REPRESENTATIVE RUFFRIDGE asked for clarity whether high
deductible plans would be exempt under the proposed legislation.
REPRESENTATIVE FIELDS explained the differences between
deductibles and delays in care.
REPRESENTATIVE RUFFRIDGE sought confirmation that the bill would
cover people covered under private insurance and would not
affect Medicaid or Medicare. Further, he inquired whether a
person with a high deductible plan would not be mandated to
cost-share under the bill.
REPRESENTATIVE FIELDS responded that's correct.
3:17:47 PM
REPRESENTATIVE PRAX welcomed invited testifiers.
3:17:59 PM
REBECCA BIRCH, Director, State Policy & Advocacy, Susan G.
Komen, said she strongly supported HB 285 and shared a story
about a patient who was "barely making ends meet" who had to
take out a loan to take the diagnostic test and the costs that
ensued because of late detection. She commented about a study
on cost averages and said high deductible plans are eliminated
with the health savings accounts.
3:21:29 PM
REPRESENTATIVE PRAX opened public testimony on HB 285.
3:22:11 PM
BEVERLY WOOLEY, representing self, testified in support of HB
285. She described her history with breast cancer and how her
ultrasound finally found a tumor. She said she was an example
of how the cost savings can be realized through early detection,
and the bill would provide an increase to much needed access.
She noted because of delayed diagnosis, 20 years out she was
still paying for follow-up care. She opined that HB 285 would
save lives and encouraged the committee to pass it without
delay.
3:25:13 PM
LISA PEABODY, FORCE - Facing Our Risk of Cancer Empowered, Inc.,
said she represented a high-risk community and testified in
support of HB 285. She further discussed high risk individuals
with a predisposition that the average person does not have.
This high-risk community, according to national guidelines,
needed their mammograms to start at age 25. In addition to
mammograms, this group may also need a breast ultrasound or MRI
every year, even when it costs hundreds of dollars, and she
opined that the proposed bill would close the gap for the high-
risk individuals.
3:27:57 PM
KELLEY MARRE, representing self, testified in support of HB 285
and shared that she was an oncology social worker. She offered
statistics on annual diagnoses and noted that men also get
breast cancer. She discussed costs and delays in diagnosis due
to the lack of affordability. She stressed that no one should
have to choose between basic needs or health care and asked the
committee to pass HB 285 so individuals would not be charged for
high-risk screening and diagnostic imaging.
3:29:53 PM
EMILY NENON, Alaska Government Relations Director, American
Cancer Society Cancer Action Network, testified in support of HB
285 and gave a history of coverage for cancer screenings. She
spoke to state-regulated plans and how they set the precedence
for what other plans do and opined that the bill would be about
setting precedence for every plan offered in the state. She
shared a story of a woman who needed follow up treatment, who
had to set aside money each month for over a year to be able to
afford the treatment, and she said the bill would help people
like her. She offered to address deductibles and [health]
savings accounts, the latter which are specific kinds of
accounts that have federal law issues. She said she looked
forward to progressing and that she was available for questions.
3:33:43 PM
REPRESENTATIVE PRAX, after ascertaining that no one else wished
to testify, closed public testimony on HB 285.
3:34:29 PM
REPRESENTATIVE RUFFRIDGE moved to report HB 285 out of committee
with individual recommendations and the accompanying fiscal
notes. There being no objection, HB 285 was reported out of the
House Health and Social Services Standing Committee.
| Document Name | Date/Time | Subjects |
|---|---|---|
| HB 285 Fiscal Note DCCED-DOI.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 285 |
| HB 285 - Komen Report.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 285 |
| HB 285 Key Highlights.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 285 |
| HB 285 - Preventing Chronic Disease.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 285 |
| HB 285 Sectional Analysis.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 285 |
| HB 285 Sponsor Statement.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 285 |
| HB 285 Version B.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 285 |
| HB 336 PHY - Letter of Opposition.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |
| HB 336 Version A.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |
| HB 336 Fiscal Note DCCED-CBPL.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |
| HB 336 APTA NATA Joint Principles.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |
| HB 336 AT PPT.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |
| HB 336 ATs in Schools.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |
| HB 336 ATs in the Armed Forces.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |
| HB 336 What is an Athletic Trainer.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |
| HB 336 Sectional Analysis 4.15.24.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |
| HB 336 Sponsor Statement 4.15.24.pdf |
HHSS 4/16/2024 3:00:00 PM |
HB 336 |